![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
0
Europe
0
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
48
PharmaCompass offers a list of Sacubitril-Valsartan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sacubitril-Valsartan manufacturer or Sacubitril-Valsartan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sacubitril-Valsartan manufacturer or Sacubitril-Valsartan supplier.
PharmaCompass also assists you with knowing the Sacubitril-Valsartan API Price utilized in the formulation of products. Sacubitril-Valsartan API Price is not always fixed or binding as the Sacubitril-Valsartan Price is obtained through a variety of data sources. The Sacubitril-Valsartan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A sacubitril valsartan sodium anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of sacubitril valsartan sodium anhydrous, including repackagers and relabelers. The FDA regulates sacubitril valsartan sodium anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. sacubitril valsartan sodium anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of sacubitril valsartan sodium anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A sacubitril valsartan sodium anhydrous supplier is an individual or a company that provides sacubitril valsartan sodium anhydrous active pharmaceutical ingredient (API) or sacubitril valsartan sodium anhydrous finished formulations upon request. The sacubitril valsartan sodium anhydrous suppliers may include sacubitril valsartan sodium anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of sacubitril valsartan sodium anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A sacubitril valsartan sodium anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of sacubitril valsartan sodium anhydrous active pharmaceutical ingredient (API) in detail. Different forms of sacubitril valsartan sodium anhydrous DMFs exist exist since differing nations have different regulations, such as sacubitril valsartan sodium anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A sacubitril valsartan sodium anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. sacubitril valsartan sodium anhydrous USDMF includes data on sacubitril valsartan sodium anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The sacubitril valsartan sodium anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of sacubitril valsartan sodium anhydrous suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a sacubitril valsartan sodium anhydrous Drug Master File in Korea (sacubitril valsartan sodium anhydrous KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of sacubitril valsartan sodium anhydrous. The MFDS reviews the sacubitril valsartan sodium anhydrous KDMF as part of the drug registration process and uses the information provided in the sacubitril valsartan sodium anhydrous KDMF to evaluate the safety and efficacy of the drug.
After submitting a sacubitril valsartan sodium anhydrous KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their sacubitril valsartan sodium anhydrous API can apply through the Korea Drug Master File (KDMF).
click here to find a list of sacubitril valsartan sodium anhydrous suppliers with KDMF on PharmaCompass.
A sacubitril valsartan sodium anhydrous written confirmation (sacubitril valsartan sodium anhydrous WC) is an official document issued by a regulatory agency to a sacubitril valsartan sodium anhydrous manufacturer, verifying that the manufacturing facility of a sacubitril valsartan sodium anhydrous active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting sacubitril valsartan sodium anhydrous APIs or sacubitril valsartan sodium anhydrous finished pharmaceutical products to another nation, regulatory agencies frequently require a sacubitril valsartan sodium anhydrous WC (written confirmation) as part of the regulatory process.
click here to find a list of sacubitril valsartan sodium anhydrous suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing sacubitril valsartan sodium anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for sacubitril valsartan sodium anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture sacubitril valsartan sodium anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain sacubitril valsartan sodium anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a sacubitril valsartan sodium anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of sacubitril valsartan sodium anhydrous suppliers with NDC on PharmaCompass.
sacubitril valsartan sodium anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of sacubitril valsartan sodium anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right sacubitril valsartan sodium anhydrous GMP manufacturer or sacubitril valsartan sodium anhydrous GMP API supplier for your needs.
A sacubitril valsartan sodium anhydrous CoA (Certificate of Analysis) is a formal document that attests to sacubitril valsartan sodium anhydrous's compliance with sacubitril valsartan sodium anhydrous specifications and serves as a tool for batch-level quality control.
sacubitril valsartan sodium anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each sacubitril valsartan sodium anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
sacubitril valsartan sodium anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (sacubitril valsartan sodium anhydrous EP), sacubitril valsartan sodium anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (sacubitril valsartan sodium anhydrous USP).